ABSTRACT
INTRODuCTION
In recent years, there has been growing interest and concern in respect to the early occurrence of cardiovascular (CV) diseases. Many investigators have observed a decline in CV mortality rates in the general population throughout the industrialized world. 1, 2 On the contrary, CV events have increased in young adults, especially in low-and middleincome regions over the past 20 years. 3 Although young adults have lower prevalence rates of traditional CV risk factors, a few considerations can be postulated to explain why heart diseases are on the rise among young individuals. Previous studies comparing young adults with their seniors with established coronary heart disease (CHD) have found that obesity, dyslipidemia, tobacco use, and illicit substance abuse were more prevalent among young adult patients. [4] [5] [6] [7] [8] [9] Also, it must be emphasized that one of the most important components in determining healthrelated behavior is the accurate perception of an individual's risk by both patients and health care providers. Physicians may underestimate the absolute CV risk of young patients, and the patients may show optimistic bias when considering their own risk and complaints. Moreover, the current risk scores unfortunately fail to identify the young individuals at risk for their first myocardial infarction (MI); as a consequence, these young adults rarely receive recommended preventive medications and lifestyle modification counseling, that could reduce the incidence of heart diseases.
There are few reports which provide information in respect to the predictors of short-term major adverse cardiovascular events (MACE) among young patients with ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (pPCI). Many studies have used ≤45 years of age as the cutoff value to describe young adults and included the entire spectrum of acute coronary syndrome (ACS) ranging from myocardial infarction to unstable angina. [10] [11] [12] Unlike previous studies, in this study we aimed to evaluate only young patients with STEMI below 40 years of age who underwent pPCI.
Mean platelet volume (MPV) represents an index of platelet size, which has been demonstrated to correlate with platelet activation. A number of studies have shown that elevated MPV concentration is significantly associated with cardiovascular conditions. [13] [14] [15] The association between elevated MPV and poor clinical outcomes in patients (without age restriction) with ACS is well documented, but less is known about MPV as a potential predictor of outcomes after STEMI in young patients. 16, 17 The purpose of this study was to examine the risk factors, clinical and angiographic characteristics of young patients with STEMI. Also, we sought to determine the role of MPV in predicting short-term outcomes of young patients with STEMI who underwent pPCI.
METHODS

Study population
The database of our tertiary referral center was searched who underwent pPCI at our institution. Patients were enrolled in the study if they fulfilled the following criteria:
(1) presented to the hospital within 12 hours of the onset of a typical chest pain lasting for >30 minutes, and (2) surface ECG showed ST segment elevation of ≥1 mm in at least two contiguous leads or ≥2 mm in leads V1 through V3, or new left bundle branch block. Coronary angiographies of the patients that fulfilled the aforementioned inclusion criteria were reviewed by two experienced interventionists using an Axiom (Siemens Medical Solution, Erlangen, Germany) workstation to confirm the existence of an identifiable culprit lesion which was intervened upon with at least plain old balloon angioplasty. No patient was excluded from the analysis. As a result, 349 young patients with STEMI admitted within 12 hours from symptom onset who underwent pPCI were included into the study.
The study was carried out according to the declaration of Helsinki, and approval from a local ethics committee was obtained. All patients gave informed consent for the study.
definitionS of demographic and clinical variableS
Demographic and clinical data of the study population, in- high thrombus burden, which was assessed according to the TIMI thrombus grading scale. 20 The presence of a noreflow phenomenon was considered if blood flow in the IRA was ≤ TIMI 2 flow despite successful dilatation and in the absence of mechanical complications. 21 If TIMI 3 flow was restored after standard therapy of no-reflow phenomenon with intravenous adenosine or nitroprusside, these procedures were assumed as successful.
laboratory analySiS and echocardiography
Venous blood samples were obtained from all patients on admission. Blood counts were determined within 30 minutes after venous blood sampling, using an autoanalyzer 
StatiStical analySiS
All data were presented as mean ± SD for parametric variables and as percentages for categorical variables. Continuous variables were checked for the normal distribution assumption using Kolmogorov-Smirnov statistics. Correlation between MPV and platelet levels was demonstrated with Pearson correlation analysis. Univariate and multivariate logistic regression analysis was performed to investigate the predictors of MACE in the study population.
Forward stepwise multivariate regression models using parameters with p <0.10 were created to identify the independent predictors of mortality. Receiver operating curves were generated to define the cutoff values for MPV. Pvalues were two-sided, and values <0.05 were considered statistically significant. All statistical studies were carried out using Statistical Package for Social Sciences software (SPSS 16.0 for Windows, SPSS Inc., Chicago, IL, USA).
RESuLTS
Our study population consisted of 349 patients ≤40 years of age (mean age 36.4 ± 3.6 years) who underwent pPCI with an admission diagnosis of acute STEMI. The majority of the study population (90%) was male, and the frequency of conventional cardiovascular risk factors was relatively low except smoking. The frequency of active smokers was 81.7% in our study population. Clinical, demographic, angiographic and procedural characteristics, laboratory results and MACE details of the patients are summarized in Table 1 . Seventy-one percent of the subjects had singlevessel disease. The culprit lesions were mostly located in the left anterior descending artery (60.2%), and anterior wall infarction (57.9%) was the most frequent type of MI.
Drug-eluting stents were used in 58.7% of the patients.
Procedural success was achieved in 331 (94.8%) patients. MACEs in the study population (Table 2) .
In ROC analysis, an MPV level >9.8 fL predicted MACEs with a sensitivity of 48% and a specificity of 92% (AUC 0.753, p <0.01). This cutoff point had 96% negative predictive value and 30% positive predictive value (Figure 1 ).
DISCuSSION
The main findings of this study were as follows: 1) in multiple logistic regression analysis admission SBP, Killip class III-IV and MPV were independent predictors of short-term MACEs in young adults with acute STEMI; 2) a low MPV value has an excellent negative predictive value for short-term outcomes; 3) MPV values were inversely correlated with the platelet counts, and 4) female gender was not found as an independent predictor of in-hospital and 30-day MACEs in young patients.
The incidence of coronary heart disease at young age has increased over the last decades, and this condition is Therefore, plaque erosion-related MI may present with sudden death without warning symptoms before the index event. In these circumstances, coronary occlusions are driven predominantly by a thrombus that develops on the eroded atherosclerotic plaque. Plaque erosion, rather than plaque rupture, is generally more prevalent in younger men and women (<40 and <50 years of age, respectively). 24 In a previous study, patients with plaque erosion were found to be more frequently smokers, but had fewer conventional coronary risk factors (dyslipidemia, HT, chronic kidney disease, and DM) than those with plaque rupture. 25 Many inflammatory markers, such as CRP, neutrophil-lymphocyte ratio, platelet-to-lymphocyte ra- previous autopsy study has found that there were fewer macrophages and T lymphocytes within the vessel wall of the patients with plaque erosion. 34 Although it has not yet been revealed in contemporary studies, we suppose that there may be a direct causal relationship between plaque morphology and blood biomarkers. Several studies were conducted to investigate the existence of any association between plaque complication type and the blood biomarkers of inflammation. In a previous optical coherence tomography (OCT)-guided study, Niccoli et al. have found that serum matrix metalloproteinase-9 and CRP levels were independently associated with plaque rupture in patients with non-STEMI. 35 Nonetheless, another OCT-guided study conducted by Ferrante et al. found no significant differences between CRP levels of ACS patients, who were divided into two groups according to the type of plaque complication -rupture or erosion. 36 Similarly, there were no significant differences between the morphology of the culprit plaque and analyzed blood biomarkers of inflammation and platelet activation in a recent study. 37 A very recent review has suggested that the widespread deployment of distinct strategies for the management of ACS (because of erosion versus rupture) could benefit enormously from the development and validation of biomarkers that indicate the underlying pathophysiology of ACS. 33 In the present study, increased MPV was identified as an independent predictor of short-term outcome. Plate- 
STuDY LIMITATIONS
This was a retrospective study from one center with a limited number of patients and carries the well-known limitation of the retrospective design. Especially, low MACE rates related to the limited number of study participants was the most important limitation of our study. Moreover, it should be highlighted that the statistical multivariate models used in this study might have been affected by the low number of events encountered among young adults.
Also, the lack of intravascular imaging modalities such as OCT limited our knowledge in respect to the plaque characteristics. Thus, our discussion, which was based on the presumption of "more frequent plaque erosion in young adult patients" is unable to go beyond an assumption.
Moreover, the shortage of data regarding inflammatory markers, such as matrix metalloproteinases, myeloperoxidase, and interleukins, can be added as another limitation of our study. Due to these limitations, the present study may serve as a hypothesis-generating research and these findings should be confirmed in a larger and adequately powered prospective cohort study. 
